-
Dirty medicine
The epic inside story of long-term criminal fraud at Ranbaxy, the Indian drug company that makes generic Lipitor for millions of Americans.
- Categories
- Health Care
- Region
- South Asia
- Tags
- public health
-
Source code: PharmaSecure goes mobile in battle against fake drugs
An initiative allowing the provenance of medicines to be verified using mobile technology is taking aim at the illegal drug trade.
- Categories
- Health Care
- Region
- South Asia
- Tags
- public health
-
World economy in a tizzy, but Indian pharma flying high
Although global economic recovery still remains fragile and the road back to normalcy is a long and difficult one, the fortunes of India’s pharmaceutical industry remain upbeat.
- Categories
- Health Care
- Region
- South Asia
- Tags
- public health
-
Godrej Appliances to enter new categories for rural consumers
Growing rural demand is making Godrej Appliances target consumers at the bottom of the pyramid with new products pegged below Rs 3,000.
- Categories
- Uncategorized
- Region
- South Asia
-
Now, a regulatory body to set norms for impact investment
In order to avoid excesses that derailed the Indian microfinance industry three years ago, nine entities doing 'impact investing' have come together.
- Categories
- Uncategorized
- Region
- South Asia
- Tags
- impact investing
-
Ramadorai new chairman of NSDC
S. Ramadorai took over the post from M.V. Subbiah, who was heading NSDC since 2008.
- Categories
- Uncategorized
- Region
- South Asia
-
Market for feature phone apps is low-tech goldmine
The next time you are standing at a bus stop, cursing the late-running service, spare a thought for Milind Dahikar.
- Categories
- Technology
- Region
- South Asia
-
Unilever Wagers Billions on India Economic Revival
In 1888, when Queen Victoria ruled India, the company that would become Unilever (UNA) decided the country was the future. More than a century on, it’s staking $5.4 billion that it still is.The Anglo-Dutch maker of Dove shampoo and Lipton tea, successor to one of the first multinationals in India, plans to spend as much as 292 billion rupees ($5.4 billion) to increase its control over Indian unit Hindustan Unilever Ltd. (HUVR)
- Region
- South Asia
